US 9156853
AKT inhibitor compounds for treatment of cancer
granted A61PA61P31/00A61P35/00
Quick answer
US patent 9156853 (AKT inhibitor compounds for treatment of cancer) held by ALMAC DISCOVERY LIMITED expires Mon Oct 08 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- ALMAC DISCOVERY LIMITED
- Grant date
- Tue Oct 13 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 08 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 23
- CPC classes
- A61P, A61P31/00, A61P35/00